Purpose
The Sarcoma Foundation of America is pleased to announce a Request for Proposals (RFP) for pre-clinical, translational, and clinical research on the etiology, molecular biology, pathogenesis, diagnosis, and treatment of human sarcomas. This RFP is in support of our overall mission to fund research and increase awareness and advocacy for sarcoma patients and their families. The goal of the SFA grant program is to encourage research that results in improved therapeutic options for sarcoma patients. The SFA encourages applications in ALL areas of sarcoma research.
Funding Availability
The total award amount is $75,000 for one year. The grants are awarded on an annual cycle from June 2, 2025, to June 1, 2026. SFA encourages applications in ALL areas of sarcoma research from U.S. and international applicants. Some grants will be supported with special funding from our donors. For 2025, dedicated funding is available in, but not limited to, the following area: leiomyosarcoma.
For each awarded grant, funding of up to $75,000 in total cost is available to cover equipment, supplies and other expenses in support of research within the period of performance. In addition, the following funding restrictions apply:
- No more than 10% of the total cost amount can be applied to indirect cost (e.g., $7,500 indirect cost toward the $75,000 total cost of the grant)
- The SFA does not permit funds to be used for Principal Investigator (PI) salaries. However, applicants are permitted to request money for the payment of salaries for non-faculty post-docs, fellows, and technicians, if applicable. No more than 50% of total cost can be used for salaries (e.g., $37,500 for the $75,000 award). Applications requesting more than this amount for salaries will not be accepted.